Metric Capital Seeking Turkish Investments After Drugmaker Deal
(Bloomberg) --
Metric Capital Partners LLP is looking for more deals in Turkey after investing more in the country's manufacturing industry than any other international private-equity company over the past two years.
The firm is taking aim at Turkey's young population relative to Europe as a well as its market of 80 million consumers, John Sinik, a co-founder of London-based Metric Capital, said in an interview. The company is seeking investments after raising 1.2 billion euros ($1.35 billion) for its fourth fund toward the end of last year.
“We're a special situations fund, which means we're focused on growth capital, shareholder consolidation and acquisition capital,” the former UBS Group AG banker said. “We're targeting good companies with good business models, but assets that may have capital needs, deleveraging needs.”
Metric Capital is stepping into a void left by the collapse of Dubai's Abraaj Group Ltd., one of the world's biggest emerging-market private equity investors. Its demise in 2018 left the market open to mainly domestic buyout companies with many international investors spooked by President Recep Tayyip Erdogan's unconventional economic policies, international relations and volatility in the local currency.
The firm earlier this year completed the purchase of a 30% stake in Sanovel Ilac Sanayi AS, Turkey's third-largest generic drug producer, with a group of investors including Istanbul-based Afendis Capital for $200 million.
Sanovel will start exporting drugs to the U.S. this month after getting approval from the Food and Drug Administration, Sinik said. The company aims to get at least 30% of its total sales through exports in the next two to three years.
Capital Boost
The capital injection from the stake sale helped Sanovel pay off loans and settle back taxes, Sinik said.
“We have de-leveraged the company and it is ready to take off.”
The drugmaker is about to conclude an agreement with an international firm to develop new products at its premises near Istanbul, with a profit-sharing arrangement, he said. It's also working with a U.S. company to sell drugs in former Soviet Union countries in Asia, and with a Middle Eastern business to sell products there and in North Africa.
In 2018, Metric Capital joined another group of investors that bought 17% of D-ream International, an entertainment management company that owns restaurant chains including Salt Bae's Nusr-et steakhouse. Its investment in Sanovel and D-ream were made from Metric Capital's third fund, according to data compiled by Bloomberg.
Asked about exit plans from the two investments, Sinik said: “D-ream is difficult to comment on. We view it as a longer-term investment because of the Covid-19 situation.”
It will review its Sanovel stake in three years. “With its new exports and other work it will be an attractive investment for investors, for large pharma,” he said.
©2020 Bloomberg L.P.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.
-
Indians Are Travelling, But Not Every Journey Is A Holiday | The Week In Whys
Pilgrims, patients and working women are the real travellers, and the system hasn't quite caught up with them.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
